Products for Research Use Only
RegisterLogin

XmAb-2513

CAT: 0931-T9901A-1897-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T9901A-1897-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Target
TNF
Related Pathways
Apoptosis
Bioactivity
XmAb-2513 is a humanized monoclonal antibody inhibitor targeting CD30. It demonstrates significant anti-proliferative activity along with excellent antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) . XmAb-2513 is applicable in research on hematological malignancies such as Hodgkin lymphoma (HL) and anaplastic large cell lymphoma (ALCL) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T80762-01XmAb 5592
T9901A-1668-01XmAb-662
T9901A-1575-01XmAb-7195
T40365T-2513
T31117CVT-2513
T63225-01T-2513 hydrochloride
T32822LM 2510
T31116CVT-2512
T15194-01EBI-2511
T27208-01DRF 2519

Alternative Products

CatalogName
HY-P991638XmAb-2513
PTX25594Anti-Human CD30/TNFRSF8 (XmAb 2513)
MBS1581298-01Research Grade Anti-Human CD30/TNFRSF8 (XmAb 2513)
A135852Anti-CD30/TNFRSF8 (XmAb 2513) Biosimilar (Monoclonal, IgG)
MBS5780739CVT-2513
GTR19189024T-2513
MBS5822416XmAb 5592
MBS5805900T-2513 hydrochloride
HY-125930AT-2513 (hydrochloride)
HY-P991252-01XmAb-7195

Popular Products